Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 465025, 16 pages
http://dx.doi.org/10.1155/2014/465025
Research Article

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine

1Otolaryngology Head and Neck Surgery, China Medical University Hospital, Taichung 40402, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Pharmacy, China Medical University, Taichung 40402, Taiwan
4Department of Biological Science and Technology, National Chiao Tung University, Hsinchu 30010, Taiwan
5Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan

Received 17 January 2014; Revised 8 February 2014; Accepted 8 February 2014; Published 2 June 2014

Academic Editor: Fuu-Jen Tsai

Copyright © 2014 Yung-An Tsou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. E. Taffet, J. F. Donohue, and P. R. Altman, “Considerations for managing chronic obstructive pulmonary disease in the elderly,” Clinical Interventions in Aging, vol. 9, pp. 23–30, 2014. View at Publisher · View at Google Scholar
  2. J. Vestbo, S. S. Hurd, A. G. Agustí et al., “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary,” The American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 4, pp. 347–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. F. J. Martinez, J. F. Donohue, and S. I. Rennard, “The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development,” The Lancet, vol. 378, no. 9795, pp. 1027–1037, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Bustacchini, C. Chiatti, G. Furneri, F. Lattanzio, and L. G. Mantovani, “The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature,” Current Opinion in Pulmonary Medicine, vol. 17, no. 1, pp. S35–S41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Najafzadeh, C. A. Marra, L. D. Lynd et al., “Future impact of various interventions on the burden of COPD in Canada: a dynamic population model,” PLoS ONE, vol. 7, no. 10, Article ID e46746, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Ozyilmaz, N. Kokturk, G. Teksut, and T. Tatlicioglu, “Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease,” International Journal of Clinical Practice, vol. 67, no. 7, pp. 691–697, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Banerjee, C. Koziol-White, and R. Panettieri Jr., “P38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD,” Current Opinion in Pharmacology, vol. 12, no. 3, pp. 287–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. I. M. Adcock, K. F. Chung, G. Caramori, and K. Ito, “Kinase inhibitors and airway inflammation,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 118–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Barnes, “Novel signal transduction modulators for the treatment of airway diseases,” Pharmacology and Therapeutics, vol. 109, no. 1-2, pp. 238–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Rajendrasozhan, S. Chung, I. K. Sundar, H. Yao, and I. Rahman, “Targeted disruption of NF-κB1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 298, no. 2, pp. L197–L209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Pannicke, B. Baumann, S. Fuchs et al., “Deficiency of innate and acquired immunity caused by an IKBKB mutation,” The New England Journal of Medicine, vol. 369, no. 26, pp. 2504–2514, 2013. View at Publisher · View at Google Scholar
  12. A. Page, M. Navarro, M. Garín et al., “IKKΒ leads to an inflammatory skin disease resembling interface dermatitis,” Journal of Investigative Dermatology, vol. 130, no. 6, pp. 1598–1610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Hu, A. Y. Gong, A. L. Roth et al., “Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense,” PLoS Pathogens, vol. 9, no. 4, Article ID e1003261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Zaph, A. E. Troy, B. C. Taylor et al., “Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis,” Nature, vol. 446, no. 7135, pp. 552–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Tsuchiya, K. Imai, K. Asamitsu, Y. Waguri-Nagaya, T. Otsuka, and T. Okamoto, “Inhibition of inflammatory cytokine production from rheumatoid synovial fibroblasts by a novel IκB kinase inhibitor,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 1, pp. 236–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. R. Aupperle, B. L. Bennett, Z. Han, D. L. Boyle, A. M. Manning, and G. S. Firestein, “NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes,” Journal of Immunology, vol. 166, no. 4, pp. 2705–2711, 2001. View at Google Scholar · View at Scopus
  17. H. H. Salem, B. Trojanowski, K. Fiedler et al., “Long-term IKK2/NF-κB signaling in pancreatic β-cells induces immune-mediated diabetes mellitus,” Diabetes, vol. 63, no. 3, pp. 960–975, 2014. View at Publisher · View at Google Scholar
  18. S. Rajendrasozhan, J. Hwang, H. Yao, N. Kishore, and I. Rahman, “Anti-inflammatory effect of a selective IκB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke,” Pulmonary Pharmacology and Therapeutics, vol. 23, no. 3, pp. 172–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. V. Kravchenko, J. C. Mathison, K. Schwamborn, F. Mercurio, and R. J. Ulevitch, “IKKi/IKKε plays a key role in integrating signals induced by pro-inflammatory stimuli,” The Journal of Biological Chemistry, vol. 278, no. 29, pp. 26612–26619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Y. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. C. Chen, S. S. Chang, F. J. Tsai, and C. Y. Chen, “Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 11, pp. 1219–1235, 2013. View at Publisher · View at Google Scholar
  22. Y.-T. Chang, W.-D. Lin, Z.-N. Chin et al., “Nonketotic hyperglycinemia: a case report and brief review,” BioMedicine, vol. 2, no. 2, pp. 80–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-L. Liao and F.-J. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. D.-Y. Lin, F.-J. Tsai, C.-H. Tsai, and C.-Y. Huang, “Mechanisms governing the protective effect of 17β-estradiol and estrogen receptors against cardiomyocyte injury,” BioMedicine, vol. 1, no. 1, pp. 21–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W.-Y. Lin, H.-P. Liu, J.-S. Chang et al., “Genetic variations within the PSORS1 region affect Kawasaki disease development and coronary artery aneurysm formation,” BioMedicine, vol. 3, no. 2, pp. 73–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. F.-J. Tsai, “Biomedicine brings the future nearer,” BioMedicine, vol. 1, no. 1, p. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. F.-J. Tsai, “Rare diseases: a mysterious puzzle,” BioMedicine, vol. 3, no. 2, p. 65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. I. C. Chou, W.-D. Lin, C.-H. Wang et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Publisher · View at Google Scholar
  29. I. C. Chou, W.-D. Lin, C.-H. Wang et al., “Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children,” BioMedicine, vol. 3, no. 2, pp. 88–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-C. Lee, C.-H. Tsai, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Publisher · View at Google Scholar
  31. C.-H. Wang, W.-D. Lin, D.-T. Bau, I. Chou, C. Tsai, and F. Tsai, “Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway,” BioMedicine, vol. 3, no. 2, pp. 82–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. C.-H. Wang, W.-D. Lin, and F.-J. Tsai, “Craniofacial dysmorphism, what is your diagnosis?” BioMedicine, vol. 2, no. 2, pp. 49–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Y. Tsai, K. W. Chang, and C. Y. C. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. C. Yang, S. S. Chang, H. Y. Chen, and C. Y. Chen, “Identification of potent EGFR inhibitors from TCM Database@Taiwan,” PLoS Computational Biology, vol. 7, no. 10, Article ID e1002189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. T. T. Chang, M. F. Sun, H. Y. Chen et al., “Screening from the world's largest TCM database against H1N1 virus,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 5, pp. 773–786, 2011. View at Google Scholar · View at Scopus
  36. K.-C. Chen and C. Y. C. Chen, “Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach,” Soft Matter, vol. 7, no. 8, pp. 4001–4008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. S. Chang, H. J. Huang, and C. Y. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K. C. Chen, M. F. Sun, S. C. Yang et al., “Investigation into potent inflammation inhibitors from traditional Chinese medicine,” Chemical Biology and Drug Design, vol. 78, no. 4, pp. 679–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Y. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Yang, S. Chang, and C. Y. Chen, “Identifying HER2 inhibitors from natural products database,” PLoS ONE, vol. 6, no. 12, Article ID e28793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. J. Huang, K. J. Lee, H. W. Yu et al., “Structure-based and ligand-based drug design for HER 2 receptor,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 1, pp. 23–37, 2010. View at Google Scholar · View at Scopus
  42. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar · View at Scopus
  43. C. Y. Chen, Y. H. Chang, D. T. Bau et al., “Ligand-based dual target drug design for H1N1: swine flu—a preliminary first study,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 2, pp. 171–178, 2009. View at Google Scholar · View at Scopus
  44. H. J. Huang and C. Y. Chen, “A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, 2013. View at Publisher · View at Google Scholar
  45. H. Y. Chen, S. S. Chang, Y. C. Chan, and C. Y. Chen, “Discovery of novel insomnia leads from screening traditional Chinese medicine database,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 5, pp. 776–791, 2014. View at Publisher · View at Google Scholar
  46. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional Chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  47. I. C. Hung, S. S. Chang, P. C. Chang, C. C. Lee, and C. Y. Chen, “Memory enhancement by traditional Chinese medicine?” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 12, pp. 1411–1439, 2013. View at Publisher · View at Google Scholar
  48. K. C. Chen, Y. R. Jian, M. F. Sun, T. T. Chang, C. C. Lee, and C. Y. Chen, “Investigation of silent information regulator 1 (Sirt1) agonists from traditional Chinese medicine,” Journal of Biomolecular Structure and Dynamics, vol. 31, no. 11, pp. 1207–1218, 2013. View at Publisher · View at Google Scholar
  49. Y. A. Tsou, K. C. Chen, H. C. Lin, S. S. Chang, and C. Y. Chen, “Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study,” PLoS ONE, vol. 7, no. 11, Article ID e50087, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Y. Chen, S. S. Chang, and C. Y. Chen, “In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine,” PLoS ONE, vol. 7, no. 9, Article ID e43932, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. H.-J. Huang, C.-C. Lee, and C. Y.-C. Chen, “Pharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 830490, 12 pages, 2014. View at Publisher · View at Google Scholar
  52. K. W. Chang, T. Y. Tsai, K. C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Google Scholar · View at Scopus
  53. S. Liu, Y. R. Misquitta, A. Olland et al., “Crystal structure of a human IκB Kinase β asymmetric dimer,” The Journal of Biological Chemistry, vol. 288, no. 31, pp. 22758–22767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Y. C. Chen and W. L. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. U. D. Priyakumar and A. D. MacKerell, “Comparison of the CHARMM27, AMBER4. 1 and BMS nucleic acid force fields via free energy calculations of base flipping,” Abstracts of Papers of the American Chemical Society, vol. 230, pp. U1391–U1392, 2005. View at Google Scholar
  57. B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. W. L. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, vol. 19, no. 4, pp. 367–372, 2014. View at Publisher · View at Google Scholar
  59. T. A. Darden and L. G. Pedersen, “Molecular modeling: an experimental tool,” Environmental Health Perspectives, vol. 101, no. 5, pp. 410–412, 1993. View at Google Scholar · View at Scopus
  60. M. Yoshikawa, S. Hatakeyama, Y. Inoue, and J. Yamahara, “Saussureamines A, B, C, D, and E, new anti-ulcer principles from Chinese Saussureae radix,” Chemical and Pharmaceutical Bulletin, vol. 41, no. 1, pp. 214–216, 1993. View at Google Scholar · View at Scopus
  61. T. Nakazawa, T. Yasuda, and K. Ohsawa, “Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice,” Journal of Pharmacy and Pharmacology, vol. 55, no. 11, pp. 1583–1591, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. K. Choi, S. G. Cho, S. M. Woo et al., “Saussurea lappa Clarke-derived costunolide prevents TNFα-induced breast cancer cell migration and invasion by inhibiting NF-κB activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 936257, 10 pages, 2013. View at Publisher · View at Google Scholar
  63. J. M. Walker, A. Maitra, J. Walker, M. M. Ehrnhoefer-Ressler, T. Inui, and V. Somoza, “Identification of Magnolia officinalis L. Bark extract as the most potent anti-inflammatory of four plant extracts,” The American Journal of Chinese Medicine, vol. 41, no. 3, pp. 531–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Y. Xie, H. Y. Di, H. Li, X. Cheng, Y. Zhang, and D. Chen, “Bupleurum chinense DC polysaccharides attenuates lipopolysaccharide-induced acute lung injury in mice,” Phytomedicine, vol. 19, no. 2, pp. 130–137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. S. N. Park, Y. K. Lim, M. O. Freire, E. Cho, D. Jin, and J. Kook, “Antimicrobial effect of linalool and α-terpineol against periodontopathic and cariogenic bacteria,” Anaerobe, vol. 18, no. 3, pp. 369–372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. R. A. Laskowski and M. B. Swindells, “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus